Sign in →

Test Code FCBDS Cannabidiol, Serum


Specimen Required


***Must submit one specimen per order. Specimens cannot be shared between multiple orders.***

 

Collection Container/Tube: Red top (Serum gel/SST are not acceptable) 

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL Serum

Collections Instructions:

1. Centrifuge and aliquot 1 mL of serum into a plastic vial.

2. Send refrigerated.

Specimen Stability Information: Ambient 14 days/Refrigerated 30 days/Frozen (-20° C) 2 years


Secondary ID

75527

Method Name

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

Cannabidiol, Serum

Specimen Type

Serum Red

Specimen Minimum Volume

Serum: 0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Red Refrigerated (preferred) 30 days
  Ambient  14 days
  Frozen 

Reject Due To

  All specimens will be evaluated by the processing and performing laboratories for test suitability.

Clinical Information

Refer to www.nmslabs.com/test-catalog.

Reference Values

Reporting limit determined each analysis

Day(s) Performed

Monday through Sunday

Report Available

11 to 13 days

Performing Laboratory

NMS Labs

CPT Code Information

80299

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FCBDS Cannabidiol, Serum 82964-8

 

Result ID Test Result Name Result LOINC Value
Z5547 Cannabidiol 82964-8

Test Classification

This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the U.S. Food and Drug Administration.

Cautions

Substance(s) known to interfere with the identity and/or quantity of the reported result: oleamide

Interpretation

Mean peak CBD plasma concentrations at 3-4 hours post-dose with Sativex at a low dose (5.4 mg of Delta-9 THC and 5.0 mg of Cannabidiol) were 1.6 ± 0.4 ng/mL and at a high dose (16 mg of Delta-9 THC and 15 mg of Cannabidiol) were 6.7 ± 2.0 ng/mL.

Following high dose 400 and 800 mg oral synthetic CBD in corn oil administration, mean peak CBD plasma concentrations occurred within 1.5-3 hours post-dose and were 181.2 ±39.8 and 221.1 ±35.6 ng/mL, respectively.

The ratio of blood to serum or plasma concentration is unknown for this analyte.